TotalMarketCap

Neuphoria Therapeutics

NEUPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$15.098 M

$2.79 -6.38%

Close of 6 Nov 2026

As of 6 Nov 2026, Neuphoria Therapeutics (NEUP) has a market capitalization of $15.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$15.6M

#3042 by revenue

Earnings

-$369.6K

Loss-making

Shares outstanding

5,411,334

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #395Citius PharmaceuticalsCTXR$15.4M
  2. #396Allarity TherapeuticsALLR$15.3M
  3. #397Neuphoria TherapeuticsNEUP$15.1M
  4. #398Marker TherapeuticsMRKR$14.9M
  5. #399Kyntra BioKYNB$14.8M

What if Neuphoria Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,218,098

Per share 1,870,286× higher

Bitcoin $1.53T

$282,342.22

Per share 101,198× higher

Apple $5.02T

$926,903.16

Per share 332,223× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Neuphoria Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.